click below
click below
Normal Size Small Size show me how
Module 2
Week 2
| Module 2 Week 2 | Module 2 Week 2 | Brand/Genetic/Class |
|---|---|---|
| a condition in which thyroid hormone secritions are above normal, often referred to as an overactive thyroid. | Hyperthyrodism | |
| An abnormal sensitivity generally resulting in an allergic reaction. | Hypersensitivity | |
| a potentially fatal hypersensitivity reaction producing severe respiratory distress and cardiovascular collapse. | Anaphylactic Shock | |
| The ability of a substance to harm the kidneys | Nephrotoxicity | |
| The ability of a substance to cause cancer. | Carcinogenicity | |
| The summation in effect when two drugs with similar pharmacological factors are taken. | Additive Effects | |
| When two drugs with similar pharmacological actions produce greater effects than the sum of individual effects. | Synergism | |
| A drug that antogonizes the toxic effects of another drug. | Antidote | |
| A drug bound to a plasma protein is removed when another drug of greater binding potential binds to the same protein. | Displacement | |
| A drug blocks the activity of metabolic enzymes in the liver. | Inhibition | |
| When element of ingested nutrients interact with a drug and effects the disposition of the drug. | Drug-Diet Interactions | |
| A chronic and potentially fatal liver disease whic occurs after long term alcohol abuse; it causes loss of function and increase resistance to blood flow through the liver. | Cirrhosis | |
| An inflammatory condition of the liver caused by viruses; the effects are less then in cirrhosis but long term exposure can progress into chronic disease with the same characteristics as cirrhosis. | Acute Viral Hepatitis | |
| A condition in which thyroid hormone secretions are below normal, often refferd to as an underactive thyroid. | Hypothyroidism | |
| Hepatotoxicity | Hepato means "of the liver". Hepatotoxicities include hepatitis, hepatic necrosis, and biliary tract inflammation or obstruction. Commonly used acetaminophen, halathane, isoniazid, chlorpromazine, methotrixate, nitrofurantion, phenytoin, aspirin. | |
| Liver disease | Hepatic Disease | |
| An unexpected reaction the first time a drug is taken, generally due the genetic causes. | Idiosyncracy | |
| The ability of a substance to cause abnormal fetal development when given to pregnent woman. | Tetratogenicity | |
| SA 1 Explain the meaning of the term "adverse effects", include example? | Adverse effects means undesired effects and some examples of this are idiosyncracy, kidney failure, anorexia, nausea, and vomiting. | |
| SA 2 Give at least 3 reasons why drug-drug interactions increase the effects of drugs? | 1 Potentation-carbidopa+dopa=prolonged half-life of dopa and increased duration of anti-Parkinsonian effec. 2 Synergism-penicillin+gentamicin=increased antibacterial effects. 3 Additive Effects-trimethoprim+sulfamethoxazole for antabiotic effects | |
| Age (Elder) | Older than 70 years of age (everything slows down, changes in cardio system, low cardiac output) slows distribution of drug molecules | |
| Pharmacogenetics (Genetics) | New field of study which defines the hereditary basis of individual differences in ADME processes. | |
| Psycological Factors | Placebo effects (sugar pill used instead of a real pill, but patients do not know , and have reported that this pill has helped them to cure the disease). | |
| Drug-Diet Interactions | 1 When elements of ingested nutrients interact with a drug and his affects the disposition of a drug. 2 Foods containing thyromine while using MAO inhibitors may produce severe hypertension or intracranial hemorrhage. | |
| Hematological Effects | Blood coagulation, bleeding, and bone marrow disorders are potentially life threatening and can be caused by various drugs. Anticoagulants can cause excessive bleeding. Antineoplastic drugs may cause bone marrow depression. | |
| Ideosyncretic Reaction | An unexpected reaction to a drug the first time it is given to a patient. Such reactions are thought to be caused by genetic characteristics that alter the patient's drug metabolizing enzymes. |